February 20, 2018

FDA OKs Clinical Trial to Test Bacteriophage-Based Treatment for Crohn’s

News

The U.S. Food and Drug Administration (FDA) recently cleared a Phase 1/2a clinical trial to study a set of bacteriophages designed to treat inflammatory bowel diseases (IBDs), specifically Crohn’s disease. ... Read more

July 14, 2015July 14, 2015

Ferring Pharmaceuticals Targeting Inflammatory Bowel Disease With Bacteriophage-based Therapy

IBD News, News

Ferring Pharmaceuticals recently initiated a new research and development collaboration with Intralytix to develop a bacteriophage-based therapy for Inflammatory Bowel Disease (IBD). InflammatoryBowel Disease (IBD) is characterized by chronic inflammation in the digestive ... Read more